Qube Research & Technologies Ltd

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1729829 LONDON, X0

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,738,956

-$18,041,025 QoQ

Shares Held

249,776

-72.7% QoQ

Ownership

0.283%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#65

of 224 holders

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. MLYS ranks #62 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	798,715	$240,437,176
2	INSM	INSMED Inc	1,682,334	$179,370,451
3	REGN	Regeneron Pharmaceuticals, Inc.	221,607	$138,180,828
4	ROIV	Roivant Sciences Ltd.	3,454,496	$122,254,613
5	AXSM	Axsome Therapeutics, Inc.	426,336	$104,354,262
6	APGE	Apogee Therapeutics, Inc.	659,678	$87,559,060
7	TVTX	Travere Therapeutics, Inc.	1,443,230	$81,989,896
8	RPRX	Royalty Pharma plc	1,412,112	$79,177,119

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,738,956	249,776	-72.7%	Shares	Sole	2026-08-14
2026-03-31	$24,779,981	914,728	+84.2%	Shares	Sole	2026-05-15
2025-12-31	$18,019,763	496,549	+175.2%	Shares	Sole	2026-02-17
2025-09-30	$6,841,753	180,426	-48.6%	Shares	Sole	2025-11-14
2025-06-30	$4,750,558	351,113	+34154.9%	Shares	Sole	2025-08-14
2024-03-31	$13,232	1,025	+41.6%	Shares	Sole	2024-05-14
2023-12-31	$6,226	724	+56.4%	Shares	Sole	2024-02-13
2023-09-30	$4,403	463	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.